204 related articles for article (PubMed ID: 9841852)
1. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac.
Rappaport JM; Bhatt SM; Burkard RF; Merchant SN; Nadol JB
J Infect Dis; 1999 Jan; 179(1):264-8. PubMed ID: 9841852
[TBL] [Abstract][Full Text] [Related]
2. Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat.
Coimbra RS; Loquet G; Leib SL
Pediatr Res; 2007 Sep; 62(3):291-4. PubMed ID: 17622952
[TBL] [Abstract][Full Text] [Related]
3. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.
Klein M; Koedel U; Pfister HW; Kastenbauer S
Ann Neurol; 2003 Oct; 54(4):451-8. PubMed ID: 14520656
[TBL] [Abstract][Full Text] [Related]
4. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis.
Worsøe L; Brandt CT; Lund SP; Østergaard C; Thomsen J; Cayé-Thomasen P
Laryngoscope; 2010 Sep; 120(9):1872-9. PubMed ID: 20717948
[TBL] [Abstract][Full Text] [Related]
5. Time course of hearing loss in an animal model of pneumococcal meningitis.
Kesser BW; Hashisaki GT; Spindel JH; Ruth RA; Scheld WM
Otolaryngol Head Neck Surg; 1999 May; 120(5):628-37. PubMed ID: 10229585
[TBL] [Abstract][Full Text] [Related]
6. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study.
Kim HH; Addison J; Suh E; Trune DR; Richter CP
Laryngoscope; 2007 Jul; 117(7):1209-15. PubMed ID: 17603319
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis.
Worsøe L; Brandt CT; Lund SP; Ostergaard C; Thomsen J; Cayé-Thomasen P
Otol Neurotol; 2010 Apr; 31(3):394-403. PubMed ID: 20147868
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of dexamethasone on hearing ability in children with pneumococcal meningitis.
Ozen M; Kanra G; Kara A; Ataş A; Seçmeer G; Ceyhan M; Cengiz AB; Belgin E
Turk J Pediatr; 2008; 50(1):23-9. PubMed ID: 18365587
[TBL] [Abstract][Full Text] [Related]
9. Cochlear preservation after meningitis: an animal model confirmation of adjunctive steroid therapy.
Addison J; Kim HH; Richter CP
Laryngoscope; 2006 Feb; 116(2):279-82. PubMed ID: 16467719
[TBL] [Abstract][Full Text] [Related]
10. The impact of dexamethasone on hearing loss in experimental pneumococcal meningitis.
Bhatt SM; Cabellos C; Nadol JB; Halpin C; Lauretano A; Xu WZ; Tuomanen E
Pediatr Infect Dis J; 1995 Feb; 14(2):93-6. PubMed ID: 7746714
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of post-meningitic cochlear injury with cerebrospinal fluid irrigation.
Yeung AH; Tinling SP; Brodie HA
Otolaryngol Head Neck Surg; 2006 Feb; 134(2):214-24. PubMed ID: 16455367
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis.
Lutsar I; Friedland IR; Jafri HS; Wubbel L; Ahmed A; Trujillo M; McCoig CC; McCracken GH
J Antimicrob Chemother; 2003 Oct; 52(4):651-5. PubMed ID: 12951330
[TBL] [Abstract][Full Text] [Related]
13. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol.
Peltola H; Roine I; Fernández J; González Mata A; Zavala I; Gonzalez Ayala S; Arbo A; Bologna R; Goyo J; López E; Miño G; Dourado de Andrade S; Sarna S; Jauhiainen T
Pediatrics; 2010 Jan; 125(1):e1-8. PubMed ID: 20008417
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone for bacterial meningitis in children.
Med Lett Drugs Ther; 1989 Jan; 31(784):6-7. PubMed ID: 2911250
[No Abstract] [Full Text] [Related]
15. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
16. [Hearing disorders in children less than 16 months of age after bacterial meningitis with reference to cerebrospinal fluid elastase].
Wilken B; van Wees J; Tegtmeyer FK; Aksu F
Klin Padiatr; 1995; 207(1):12-6. PubMed ID: 7885011
[TBL] [Abstract][Full Text] [Related]
17. MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis.
Klein M; Schmidt C; Kastenbauer S; Paul R; Kirschning CJ; Wagner H; Popp B; Pfister HW; Koedel U
J Infect Dis; 2007 Apr; 195(8):1189-93. PubMed ID: 17357057
[TBL] [Abstract][Full Text] [Related]
18. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes.
Brandt CT; Cayé-Thomasen P; Lund SP; Worsøe L; Ostergaard C; Frimodt-Møller N; Espersen F; Thomsen J; Lundgren JD
Neurobiol Dis; 2006 Aug; 23(2):300-11. PubMed ID: 16798006
[TBL] [Abstract][Full Text] [Related]
19. Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis.
Buckingham SC; McCullers JA; Luján-Zilbermann J; Knapp KM; Orman KL; English BK
Pediatrics; 2006 May; 117(5):1688-94. PubMed ID: 16651325
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
Liu X; Han Q; Sun R; Li Z
Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
